Cellibre to Participate in the Jefferies 2023 Global Healthcare Conference
05 Jun 2023
SAN DIEGO, June 5, 2023 /PRNewswire/ -- Cellibre Inc., a leading manufacturing technology company, today announced that the team will participate in the Jefferies 2023 Global Healthcare Conference taking place June 7-9, 2023 in New York, NY.
About Cellibre
Cellibre is a manufacturing technology company that employs an organism-agnostic approach to turn cells into specialized, sustainable factories for the manufacture of globally significant products at scale. Cellibre's world-class scientific team has led programs from napkin to commercial, pioneering revolutionary breakthroughs in energy, ingredients, medicines and more. The Company's initial strategic focus will be deploying our expertise to enable the production of pharmaceutical-grade cannabinoids, alleviating the need for agriculture entirely and revolutionizing the way cannabinoid ingredients are sourced, produced and consumed.
Cellibre was founded in 2017 and headquartered in San Diego, California.
For more information visit , or reach us by emailing contact@cellibre.com
Follow Cellibre on social media: LinkedIn
View original content to download multimedia:
SOURCE Cellibre, Inc.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
-Targets
-Drugs
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.